AnvilCore Research
CJC-1295 w/o DAC IPA research material is available in 1 format. Select a tab to review the available strength.
Technical research description
This research blend combines a shorter-acting modified GHRH(1-29) analogue commonly labeled CJC-1295 without DAC with ipamorelin, a selective ghrelin-receptor growth-hormone secretagogue. The two components engage different receptors within the GH/IGF-1 axis; evidence for the fixed combination is limited.
This research blend combines a shorter-acting modified GHRH(1-29) analogue commonly labeled CJC-1295 without DAC with ipamorelin, a selective ghrelin-receptor growth-hormone secretagogue. The two components engage different receptors within the GH/IGF-1 axis; evidence for the fixed combination is limited.
Component sequences
CJC no DAC: Tyr — D-Ala — Asp — Ala — Ile — Phe — Thr — Gln — Ser — Tyr — Arg — Lys — Val — Leu — Ala — Gln — Leu — Ser — Ala — Arg — Lys — Leu — Leu — Gln — Asp — Ile — Leu — Ser — Arg — NH₂
Ipamorelin: Aib — His — D-2-Nal — D-Phe — Lys — NH₂
Ipamorelin: Aib — His — D-2-Nal — D-Phe — Lys — NH₂
Two-component research blend.
CJC-1295 w/o DAC IPA — 5×5 mg
- Strength
- 5×5 mg
- Format
- Powder
- Retail price (USD)
- $34.00
Adds CJC-1295 w/o DAC IPA — 5×5 mg to your cart. Research and laboratory use only.
Research use only. Not for human consumption or clinical, diagnostic, or therapeutic use.